Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Endocrine 1Dermatologic 1

Conditions

Anxiety Disorders 6Neoplasms 5Pain 4Sleep Initiation and Maintenance Disorders 3Prostatic Neoplasms 2Nausea 2Hematopoietic and Lymphatic System Neoplasm 2Breast Neoplasms 2Vomiting 1Skin Neoplasms 1Sarcoma 1Respiratory Aspiration 1Neuroblastoma 1Melanoma 1Lymphoma 1Leukemia 1Hodgkin Disease 1Gastrointestinal Neoplasms 1Fatigue 1Dyspnea 1Depression 1Colorectal Neoplasms 1Colonic Polyps 1Chemotherapy Effect 1Carcinoma, Neuroendocrine 1Brain Neoplasms 1Anorexia 1

Interventions

Oxaliplatin 29Fluorouracil 25Leucovorin 20Capecitabine 18Irinotecan 17Surveys and Questionnaires 16Bevacizumab 14Cisplatin 12Blood Specimen Collection 11Drug Therapy 10Standard of Care 9Nivolumab 9Gemcitabine 9Cetuximab 7pembrolizumab 6Specimen Handling 6S 1 (combination) 6Endoscopic Mucosal Resection 6Cyclophosphamide 6atezolizumab 5Sunitinib 5Radiotherapy 5Folfox protocol 5Educational Status 5Docetaxel 5fludarabine 4aldesleukin 4Radiosurgery 4Pemetrexed 4Magnetic Resonance Spectroscopy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × Aromatherapy × Clear all
NCT03858855 2020-08-04

Inhaled Essential Oil Effect on Common QOL Concerns During Cancer Treatment

Ohio State University Comprehensive Cancer Center

Phase NA Completed
248 enrolled
DermatologicEndocrineGastrointestinal

Gastrointestinal Neoplasms, Melanoma, Skin Neoplasms, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡